↓ Cooling
Business
🔮 holds
Eli Lilly's Market Cap Balloons, Again, On This IPO's Setback
Eli Lilly's market capitalization has risen following a setback for Kailera's oral GLP-1 obesity drug trials in China.
Kailera
1 trends tracked about this subject — the full history, oldest to newest below.